Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients
Open Access
- 27 July 2005
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 118 (2) , 412-421
- https://doi.org/10.1002/ijc.21332
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Identification of metastasis‐associated proteins in a human tumor metastasis model using the mass‐mapping techniqueProteomics, 2004
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2004
- Polymorphisms in the one‐carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective studyInternational Journal of Cancer, 2004
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Emerging molecular markers of cancerNature Reviews Cancer, 2002
- TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 and Inhibits SenescencePublished by Elsevier ,2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer PredictionGynecologic Oncology, 2001
- Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndromeNature Genetics, 1997